Skip to main content

Whole-body MRI in patients with lymphoma: collateral findings

La radiologia medica volume 121, pages 793–800 (2016)Cite this article

Abstract

Purpose

To assess the incidence of collateral findings detected on whole-body magnetic resonance (WB-MRI) scans performed on patients with lymphoma.

Materials and methods

114 patients (65 male; median age 45.2 years, range 15–86) with histologically confirmed lymphoma (47 Hodgkin, 67 Non-Hodgkin) underwent WB-MRI. The collateral findings were classified into three classes, according to their clinical significance, as follows: not or low significant (class 1), moderately or potentially significant (class 2), and significant (class 3). A Chi-square (χ 2) test was performed to assess the statistical significance of differences in the incidence of collateral findings based on age (≤50 and >50 years old), gender and histology (Hodgkin and Non-Hodgkin Lymphoma).

Results

Ninety-one of 114 patients (79.8 %) had one or more incidental findings on WB-MRI. Collateral findings were more frequent in class 1 (43 %); abnormalities found in 35 patients (30.7 %) were considered potentially significant, whereas seven patients (6.1 %) demonstrated significant collateral findings requiring immediate treatment or further diagnostic evaluation. Collateral findings were more frequent in subjects over 50 years old compared to those of 50 years old or younger; differences were statistical significant (χ 2 = 8.42, p < 0.05). There were not statistically significant differences related to gender (χ 2 = 0.17, p > 0.05) and histology (χ 2 = 0.24, p > 0.05).

Conclusion

WB-MRI is an attractive procedure that allows to detect incidental abnormalities of organs not involved by disease offering the opportunity to obtain an early diagnosis of asymptomatic life-threatening diseases.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3

References

  1. Lin C, Itti E, Luciani A, Haioun C, Meignan M, Rahmouni A (2010) Whole-body diffusion-weighted imaging in lymphoma. Cancer Imaging 10:S172–S178

    Article  PubMed  PubMed Central  Google Scholar 

  2. Lin C, Luciani A, Itti E et al (2010) Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma. Eur Radiol 20:2027–2038

    Article  PubMed  Google Scholar 

  3. Abdulqadhr G, Molin D, Aström G et al (2011) Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients. Acta Radiol 52:173–180

    Article  PubMed  Google Scholar 

  4. Albano D, Patti C, La Grutta L et al (2016) Comparison between whole-body MRI with diffusion-weighted imaging and PET/CT in staging newly diagnosed FDG-avid lymphomas. Eur J Radiol 85:313–318

    Article  PubMed  Google Scholar 

  5. Wu X, Kellokumpu-Lehtinen PL, Pertovaara H et al (2011) Diffusion weighted MRI in early chemotherapy response evaluation of patients with diffuse large B-cell lymphoma—a pilot study: comparison with 2-deoxy-2-fluoro-d-glucose-positron emission tomography/computed tomography. NMR Biomed 24:1181–1190

    CAS  Article  PubMed  Google Scholar 

  6. De Paepe K, Bevernage C, De Keyzer F et al (2013) Whole-body diffusion-weighted magnetic resonance imaging at 3 T for early assessment of treatment response in non-Hodgkin lymphoma: a pilot study. Cancer Imaging 13:53–62

    Article  PubMed  PubMed Central  Google Scholar 

  7. Wu X, Nerisho S, Dastidar P et al (2013) Comparison of different MRI sequences in lesion detection and early response evaluation of diffuse large B-cell lymphoma: a whole body MRI and diffusion-weighted imaging study. NMR Biomed 26:1186–1194

    Article  PubMed  Google Scholar 

  8. Tsuji K, Kishi S, Tsuchida T et al (2015) Evaluation of staging and early response to chemotherapy with whole-body diffusion-weighted MRI in malignant lymphoma patients: a comparison with FDG-PET/CT. J Magn Reson Imaging 41:1601–1607

    Article  PubMed  Google Scholar 

  9. Kwee TC, Takahara T, Ochiai R et al (2010) Complementary roles of whole-body diffusion-weighted MRI and 18F-FDG PET: the state of the art and potential applications. J Nucl Med 51:1549–1558

    Article  PubMed  Google Scholar 

  10. Kwee TC, Takahara T, Ochiai R et al (2008) Diffusion-weighted whole body imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol 18:1937–1952

    Article  PubMed  PubMed Central  Google Scholar 

  11. Cieszanowski A, Maj E, Kulisiewicz P et al (2014) Non-contrast-enhanced whole-body magnetic resonance imaging in the general population: the incidence of abnormal findings in patients 50 years old and younger compared to older subjects. PLoS One 26(9):e107840

    Article  Google Scholar 

  12. Schmidt CO, Hegenscheid K, Erdmann P et al (2013) Psychosocial consequences and severity of disclosed incidental findings from whole-body MRI in a general population study. Eur Radiol 23:1343–1351

    Article  PubMed  Google Scholar 

  13. Hegenscheid K, Seipel R, Schmidt CO et al (2013) Potentially relevant incidental findings on research whole-body MRI in the general adult population: frequencies and management. Eur Radiol 23:816–826

    Article  PubMed  Google Scholar 

  14. Hegenscheid K, Kühn JP, Völzke H, Biffar R, Hosten N, Puls R (2009) Whole-body magnetic resonance imaging of healthy volunteers: pilot study results from the population-based SHIP study. Rofo 181:748–759

    CAS  Article  PubMed  Google Scholar 

  15. Morin SH, Cobbold JF, Lim AK et al (2009) Incidental findings in healthy control research subjects using whole-body MRI. Eur J Radiol 72:529–533

    CAS  Article  PubMed  Google Scholar 

  16. Lo GG, Ai V, Au-Yeung KM, Chan JK, Li KW, Chien D (2008) Magnetic resonance whole body imaging at 3 Tesla: feasibility and findings in a cohort of asymptomatic medical doctors. Hong Kong Med J 14:90–96

    PubMed  Google Scholar 

  17. Illes J, Kirschen MP, Karetsky K et al (2004) Discovery and disclosure of incidental findings in neuroimaging research. J Magn Reson Imaging 20:743–747

    Article  PubMed  PubMed Central  Google Scholar 

  18. La Grutta L, Malagò R, Maffei E et al (2015) Collateral non cardiac findings in clinical routine CT coronary angiography: results from a multi-center registry. Radiol Med 120:1122–1129

    Article  PubMed  Google Scholar 

  19. Cademartiri F, Malagò R, Belgrano M et al (2007) Spectrum of collateral findings in multislice CT c, oronary angiography. Radiol Med 112:937–948

    CAS  Article  PubMed  Google Scholar 

  20. Sconfienza LM, Mauri G, Muzzupappa C et al (2015) Relevant incidental findings at abdominal multi-detector contrast-enhanced computed tomography: a collateral screening? World J Radiol 28(7):350–356

    Article  Google Scholar 

  21. Padia SA, Freyvogel M, Dietz J et al (2016) False-positive extra-mammary findings in breast MRI: another cause for concern. Breast J 22:90–95

    Article  PubMed  Google Scholar 

  22. Rinaldi P, Costantini M, Belli P et al (2011) Extra-mammary findings in breast MRI. Eur Radiol 21:2268–2276

    Article  PubMed  Google Scholar 

  23. Pickhardt PJ, Choi JR, Hwang I et al (2003) Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 349:2191–2200

    CAS  Article  PubMed  Google Scholar 

  24. Yee J, Kumar NN, Godara S et al (2005) Extracolonic abnormalities discovered incidentally at CT colonography in a male population. Radiology 236:519–526

    Article  PubMed  Google Scholar 

  25. Kim BS, Illes J, Kaplan RT, Reiss A, Atlas SW (2002) Incidental findings on pediatric MR images of the brain. AJNR Am J Neuroradiol 23:1674–1677

    PubMed  Google Scholar 

  26. Baker LC, Atlas SW, Afendulis CC (2008) Expanded use of imaging technology and the challenge of measuring value. Health Aff (Millwood) 27:1467–1478

    Article  Google Scholar 

  27. Quattrocchi CC, Giona A, Di Martino AC et al (2013) Extra-spinal incidental findings at lumbar spine MRI in the general population: a large cohort study. Insights Imaging 4:301–308

    Article  PubMed  PubMed Central  Google Scholar 

  28. Albano D, La Grutta L, Grassedonio E et al (2016) Pitfalls in whole body MRI with diffusion weighted imaging performed on patients with lymphoma: what radiologists should know. Magn Res Imaging 34:922–931

    Article  Google Scholar 

  29. Schmidt GP, Baur-Melnyk A, Herzog P et al (2005) High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system. Invest Radiol 40:743–753

    Article  PubMed  Google Scholar 

  30. Ghanem NA, Pache G, Lohrmann C et al (2007) MRI and (18) FDG-PET in the assessment of bone marrow infiltration of the spine in cancer patients. Eur Spine J 16:1907–1912

    Article  PubMed  PubMed Central  Google Scholar 

  31. Giles SL, deSouza NM, Collins DJ et al (2015) Assessing myeloma bone disease with whole-body diffusion-weighted imaging: comparison with x-ray skeletal survey by region and relationship with laboratory estimates of disease burden. Clin Radiol 70:614–621

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  32. Fosså A, Fiskvik IH, Kolstad A et al (2012) Two escalated followed by six standard BEACOPP in advanced-stage high-risk classical Hodgkin lymphoma: high cure rates but increased risk of aseptic osteonecrosis. Ann Oncol 23:1254–1259

    Article  PubMed  Google Scholar 

  33. Orme NM, Fletcher JG, Siddiki HA et al (2010) Incidental findings in imaging research: evaluating incidence, benefit, and burden. Arch Intern Med 170:1525–1532

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Radiology, DIBIMED, University of Palermo, Via del Vespro 127, 90127, Palermo, Italy

    Massimo Galia, Domenico Albano, Donatella Narese, Emanuele Grassedonio, Ludovico La Grutta, Roberto Lagalla & Massimo Midiri

  2. Department of Hematology I, Azienda Ospedali Riuniti Villa Sofia-Cervello, Viale Strasburgo 233, 90146, Palermo, Italy

    Caterina Patti & Antonino Mulè

  3. Dipartimento di Scienze Biomediche Avanzate, Università degli studi Federico II, Via Pansini 5, 80131, Naples, Italy

    Vito Chianca

  4. Dipartimento di Diagnostica per Immagini, AORN A. Cardarelli, Via Antonio Cardarelli 9, 80131, Naples, Italy

    Francesco Di Pietto

Authors
  1. Massimo Galia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Domenico Albano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Donatella Narese
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Caterina Patti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vito Chianca
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Francesco Di Pietto
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Antonino Mulè
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Emanuele Grassedonio
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ludovico La Grutta
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Roberto Lagalla
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Massimo Midiri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Domenico Albano.

Ethics declarations

Conflict of interests

The authors declare that they have no conflict of interest.

Ethical standards

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Galia, M., Albano, D., Narese, D. et al. Whole-body MRI in patients with lymphoma: collateral findings. Radiol med 121, 793–800 (2016). https://doi.org/10.1007/s11547-016-0658-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11547-016-0658-x

Keywords

  • Magnetic resonance imaging
  • Whole-body imaging
  • Lymphoma
  • Collateral findings